The T1E28z receptor specifically targets ErbB dimers, which are frequently overexpressed in HNSCC, while the 4ab receptor promotes T-cell proliferation through activation of key signaling pathways, including STAT3, STAT5, and ERK. Here, EGFR is linked to head and neck squamous cell carcinoma.